ERBB2 and neoplasm: In addition, an adoptive transfer of γδ T cells with [(HER2)2xCD16] or [(HER2)2xVγ9] could enhance their cytotoxicity and support the anti-tumor response of innate cells activated via [(HER2)2xCD16].